Leiras – a part of the Finnish health care over 60 years
Leiras is a growing pharmaceutical marketing and sales company whose extensive portfolio consist of both original and cost-effective generic medicines for various diseases and therapy areas. An extensive range of OTC products completes the portfolio.
Leiras is a pharma marketing expert in Finnish health care and our partner companies will benefit from our local knowledge and our global experience through our parent company Nycomed. Our primary aim at Leiras is to bring to the market new, innovative and cost-effective medicines, that make real difference to Finnish patients and health society.
Leiras is one of the top 10 leading pharmaceutical companies in Finland, as our position was 3rd in total volume of sales and position 7th in total value of sales.
The commitment, competence and creative power of our people, have made Leiras a steadily growing pharmaceutical company and a preferred partner to many foreign and domestic suppliers.. Our employees are our greatest asset,at your service.
Our fully developed ethical and OTC marketing and sales departments with experienced sales force teams throughout the whole Finland are commited to provide the latest scientific and marketing information of our products to the health care professionals and pharmacists through face-to-face visits and disease & product training sessions.
Our medical department, with dedicated local medical advicers and extensive experienced regulatory affairs specialists, are ensuring the fastest possible regulatory handling and smooth market entries within the frames of of current regulations. The rapid market access is supported with our professional healtheconomic department, making price and reimbursement applications.
Leiras is dedicated to marketing of pharmaceuticals that will make a real difference to Finnish patients.
Our business consists of prescription medicines for therapy areas like: gastrointestinal and cardiovascular diseases (hypertension & type 2 diabetes ), pain, respiratory and allergy, speciality products for hopitals. We also provide fairly large generic portfolio. OTC business is one of the core business of the Leiras, representing around one thrid of our total turnover.
Please read more about our areas of interest